Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowance for credit losses $ 191 $ 182
Preferred stock, shares authorized 50,000,000 50,000,000
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 600,000,000 600,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares issued 201,279,662 199,413,917
Common stock, shares outstanding 201,279,662 199,413,917